Cargando…
Selective Suppression of the Generation of Anti‐tumor L3T4(+) but Not of Lyt‐2(+) T Cell‐mediated Immunity in the Tumor‐hearing State
C3H/He mice hyperimmune against syngeneic MH134 hepatoma were prepared by intradermal (id) inoculation of viable tumor cells followed by surgical resection of the tumor and by repeated id challenges with viable tumor cells. Winn assays performed utilizing spleen cells from these mice have revealed t...
Autores principales: | Sano, Haruo, Sato, Soichiro, Shima, Junko, Tada, Tsuyoshi, Fujiwara, Hiromi, Hamaoka, Toshiyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
1988
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5917588/ https://www.ncbi.nlm.nih.gov/pubmed/3139599 http://dx.doi.org/10.1111/j.1349-7006.1988.tb00048.x |
Ejemplares similares
-
Mediation of in vivo Tumor‐neutralizing Activity by Lyt‐2(+) as Well as L3T4(+) T Cell Subsets
por: Yoshioka, Takayuki, et al.
Publicado: (1988) -
Mechanisms for Recognition of Tumor Antigens and Mediation of Anti‐tumor Effect by Noncytolytic Lyt‐2(+) T Cell Subset
por: Sakamoto, Kohichi, et al.
Publicado: (1988) -
Suppression of Anti‐tumor CD4(+) T Cell Responsiveness in the Tumor‐bearing State and Its Recovery in in vitro Culture Free of Tumor Burden
por: Nagata, Takako, et al.
Publicado: (1993) -
Tumor‐specific T Cell Lines: Capacity to Proliferate and Produce Interleukin 2 in Response to Various Forms of Tumor Antigens
por: Shimizu, Jun, et al.
Publicado: (1992) -
Effect of in vivo administration of Lyt antibodies. Lyt phenotype of T cells in lymphoid tissues and blocking of tumor rejection
Publicado: (1985)